Compounds > cefotaxime

cefotaxime and Mucocutaneous-Lymph-Node-Syndrome

cefotaxime has been researched along with Mucocutaneous-Lymph-Node-Syndrome* in 2 studies

Other Studies

2 other study(ies) available for cefotaxime and Mucocutaneous-Lymph-Node-Syndrome

ArticleYear
A Case of Intravenous Immunoglobulin-Resistant Kawasaki Disease With Yersinia enterocolitica Enterocolitis Successfully Treated With Cefotaxime Following Infliximab and Cyclosporine.
    Journal of the Pediatric Infectious Diseases Society, 2021, Mar-26, Volume: 10, Issue:2

    Topics: Cefotaxime; Cyclosporine; Enterocolitis; Humans; Immunoglobulins, Intravenous; Infliximab; Mucocutaneous Lymph Node Syndrome; Yersinia enterocolitica

2021
Antibiotic use in children with Kawasaki disease.
    World journal of pediatrics : WJP, 2018, Volume: 14, Issue:6

    Topics: Age Factors; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; C-Reactive Protein; Cefotaxime; Child, Preschool; Diagnosis, Differential; Diagnostic Errors; Female; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Infant; Leukocytosis; Male; Mucocutaneous Lymph Node Syndrome; Pyuria; Republic of Korea; Retrospective Studies; Sulbactam

2018